We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

40 hedge funds and large institutions have $11.2M invested in Pear Therapeutics, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more capital invested

Capital invested by funds: $4.47M → $11.2M (+$6.72M)

9% less funds holding

Funds holding: 44 → 40 (-4)

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
40
Holders Change
-4
Holders Change %
-9.09%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
10
Closed
5
Calls
$2.19M
Puts
–
Net Calls
+$2.19M
Net Calls Change
-$321K

Top Buyers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
+$881K
2
UBS Group
UBS Group
Switzerland
+$1.29K
3
Jane Street
Jane Street
New York
+$755
4
TI
Telemetry Investments
New York
+$168
5
SCA
Sandy Cove Advisors
Massachusetts
+$23

Top Sellers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
-$246K
2
KCM
Kingstown Capital Management
New York
-$129K
3
AGM
Alpine Global Management
New York
-$96K
4
CL
CSS LLC
Illinois
-$31K
5
ICMH
Integrity Capital Management (HK)
Hong Kong
-$30K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$6.67M +$881K +1,258,733 +2,027%
HCM
2
Highbridge Capital Management
New York
$1.41M – – –
PSAMP
3
P. Schoenfeld Asset Management (PSAM)
New York
$378K – – –
OCAM
4
Owl Creek Asset Management
New York
$328K – – –
KC
5
Kepos Capital
New York
$198K – – –
BlackRock
6
BlackRock
New York
$191K -$1.15K -1,643 -0.7%
AR
7
Advisory Research
Illinois
$169K – – –
AGC
8
Angelo Gordon & Co
New York
$168K – – –
KCM
9
Kingstown Capital Management
New York
$158K -$129K -185,000 -48%
SC
10
Sculptor Capital
New York
$156K -$560 -800 -0.4%
SRF
11
Silver Rock Financial
California
$149K – – –
MCM
12
Moore Capital Management
New York
$132K – – –
Balyasny Asset Management
13
Balyasny Asset Management
Illinois
$119K – – –
DCM
14
Difesa Capital Management
New York
$119K – – –
AI
15
Arena Investors
New York
$100K – – –
TCA
16
Taconic Capital Advisors
New York
$79K – – –
TI
17
Telemetry Investments
New York
$68K +$168 +240 +0.3%
CF
18
Cantor Fitzgerald
New York
$63K -$70 -100 -0.1%
DKCM
19
Davidson Kempner Capital Management
New York
$63K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$60K -$2.26K -3,233 -4%
PI
21
PEAK6 Investments
Illinois
$53K – – –
WCMNY
22
Westchester Capital Management (New York)
New York
$51K – – –
CCA
23
Castle Creek Arbitrage
Colorado
$46K -$280 -400 -0.7%
MA
24
MYDA Advisors
New York
$45K -$1.99K -2,838 -5%
Hudson Bay Capital Management
25
Hudson Bay Capital Management
Connecticut
$43K – – –
1
2

PEARW Hedge Fund Activity: Q1 2022 in Review

40 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q1 2022, worth a combined $11.2M — up 150% from $4.47M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of PEARW and 1 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.

The largest buyer was LMR Partners, adding an estimated $881K. The largest seller was Aristeia Capital, exiting entirely with an estimated $246K sold.

  • 40 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q1 2022, down from 44 in Q4 2021.
  • Funds reported $11.2M of Pear Therapeutics, Inc. Warrant stock for Q1 2022, up 150% quarter-over-quarter.
  • 1 fund opened new Pear Therapeutics, Inc. Warrant positions in Q1 2022 and 5 closed out, a net change of -4 holders.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q1 2022 was LMR Partners, an estimated $881K added.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q1 2022 was Aristeia Capital, an estimated $246K sold.

Based on aggregated 13F filings for Q1 2022.